![Acorda Therapeutics, Inc. logo](/logos/ACOR.webp)
Acorda Therapeutics, Inc.
NASDAQ:ACOR
Overview | Financials
Company Name | Acorda Therapeutics, Inc. |
Symbol | ACOR |
Currency | USD |
Price | 0.661 |
Market Cap | 821,028 |
Dividend Yield | 0% |
52-week-range | 0.612 - 24.2 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Ron Cohen M.D. |
Website | https://www.acorda.com |
An error occurred while fetching data.
About Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD